Form 8-K AbbVie Inc. For: Oct 28

Go back to Form 8-K AbbVie Inc. For: Oct 28

AbbVie director resigns to become CEO of Align Technology

November 2, 2026 4:10 PM EST

Jennifer L. Davis notified AbbVie Inc.'s (NYSE: ABBV) Board of Directors on October 28, 2026, of her intent to resign as a Class II director, effective November 2, 2026.

Davis cited her recent appointment as Chief Executive Officer of Align Technology, Inc. as the... More